pfizer

Pfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016

Pfizer announced it will buy migraine drug maker Biohaven for about $11.6 billion – in cash.

Top 3 Safe Stocks for Conservative Investors

It just so happens that many of these lower volatility stocks have been outperforming the market, which tells us that investors are flocking to low-volatility investments at this time.

Sean Sechler

US Regulators Authorize COVID-19 Vaccine Booster Doses for 16- and 17-Year-Olds

The decision drew immediate pushback, with experts noting that young, healthy people are at low risk of severe COVID-19 and at elevated risk of heart inflammation following vaccination.

Pfizer Deal Lets Outside Companies Make Drugmaker's COVID-19 Pill

The deal lets manufacturers in certain countries produce the pill, provided they don't try to sell it in a certain set of other nations.

The Epoch Times

Walgreens Responds After Family Says Children Received COVID-19 Vaccine Instead of Flu Shot

Indiana family said their two young children got two full adult doses of the Pfizer COVID-19 vaccine instead of influenza shots.

The Epoch Times

Merck Says Antiviral Pill for COVID-19 Is Effective, Plans to File for Emergency Authorization

The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial.

Merck Says Experimental Covid-19 Pill Cuts Risk of Death by 50%

If approved, the drug would be the first pill effective against Covid-19.

More Than 30 Companies, Including Amazon, Facebook and Pfizer Vow to Create Economic Opportunities for Afghan Refugees

The 34 companies have joined the Tent Coalition for Afghan Refugees, which aims to integrate Afghan refugees into the United States.

The Epoch Times

Pfizer Says COVID-19 Vaccine Efficacy Weakens Over Time

Pfizer said that booster doses should be given to all people aged 16 and older six months after they received their second dose of the mRNA vaccine.

The Epoch Times

First Patient Gets Dose in Pfizer's Oral COVID-19 Drug Trial

"If successful, we believe this therapy could help reduce severity of illness among a broad population of patients," Rod MacKenzie, Pfizer's chief development officer, said in a statement.

Vaccine-Maker BioNTech Sees 2nd-Quarter Profits Soar

In an earnings report released on Monday, the Mainz-based company said that it made a net profit of nearly $3.3 billion between April and June.